Pekka Suhonen
- Pharmaceutical Science top 2%
- Molecular Biology
- Public Health, Environmental and Occupational Health
- Radiology, Nuclear Medicine and Imaging
- Ophthalmology top 5%
- Co-authors
- Arto UrttiTomi JärvinenVeli‐Pekka RantaElisa ToropainenPekka PeuraHannu KokkiSeppo AuriolaPekka Jarho
- Topics
- Advanced Drug Delivery Systems (5 papers)Drug Transport and Resistance Mechanisms (3 papers)Phytochemistry and Biological Activities (3 papers)
- Partner nations
- Finland
In The Last Decade
Pekka Suhonen
23 papers receiving 592 citations
Peers
Comparison fields: 5 of 87
- Pharmaceutical Science 226
- Molecular Biology 217
- Public Health, Environmental and Occupational Health 124
- Radiology, Nuclear Medicine and Imaging 92
- Ophthalmology 76
Countries citing papers authored by Pekka Suhonen
This map shows the geographic impact of Pekka Suhonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pekka Suhonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pekka Suhonen more than expected).
Fields of papers citing papers by Pekka Suhonen
This network shows the impact of papers produced by Pekka Suhonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pekka Suhonen. The network helps show where Pekka Suhonen may publish in the future.
Co-authorship network of co-authors of Pekka Suhonen
This figure shows the co-authorship network connecting the top 25 collaborators of Pekka Suhonen. A scholar is included among the top collaborators of Pekka Suhonen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pekka Suhonen. Pekka Suhonen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 53 | |
| 2 | Paracellular and Transcellular Permeability in Human Corneal Epithelial Cell Culture Model | 3 |
| 3 | 19 | |
| 4 | 83 | |
| 5 | 28 | |
| 6 | 21 | |
| 7 | 49 | |
| 8 | 8 | |
| 9 | 16 | |
| 10 | 50 | |
| 11 | 18 | |
| 12 | 5 | |
| 13 | 5 | |
| 14 | 12 | |
| 15 | 21 | |
| 16 | 10 | |
| 17 | 30 | |
| 18 | 8 | |
| 19 | Alvar Aalto luonnoksia | 1 |
| 20 | 0 |
About Pekka Suhonen
Pekka Suhonen is a scholar working on Pharmaceutical Science, Pharmacology and Ophthalmology, having authored 24 papers that have together received 609 indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (5 papers), Drug Transport and Resistance Mechanisms (3 papers) and Phytochemistry and Biological Activities (3 papers). The work is most often cited by research in Pharmaceutical Science (226 citations), Ophthalmology (76 citations) and Anesthesiology and Pain Medicine (42 citations). Pekka Suhonen has collaborated with scholars based in Finland. Frequent co-authors include Arto Urtti, Tomi Järvinen, Veli‐Pekka Ranta, Elisa Toropainen, Pekka Peura, Hannu Kokki, Seppo Auriola, Pekka Jarho, David W. Pate and Jouko Vepsäläinen. Their work appears in journals such as Journal of Chromatography A, International Journal of Pharmaceutics and Pharmaceutical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.